Piper Sandler Lowers Vicarious Surgical (NYSE:RBOT) Price Target to $10.50

Vicarious Surgical (NYSE:RBOT) had its target price lowered by investment analysts at Piper Sandler from $12.00 to $10.50 in a research note issued on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s target price suggests a potential upside of 12.42% from the stock’s current price.

Vicarious Surgical Stock Performance

Shares of RBOT stock traded down $1.80 during trading on Wednesday, hitting $9.34. The company’s stock had a trading volume of 35,712 shares, compared to its average volume of 25,720. The business has a fifty day moving average of $6.89 and a 200-day moving average of $7.63. Vicarious Surgical has a 52 week low of $4.27 and a 52 week high of $21.43.

Vicarious Surgical (NYSE:RBOT) last released its earnings results on Monday, August 12th. The company reported ($2.86) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.98) by $0.12. As a group, sell-side analysts expect that Vicarious Surgical will post -10.07 earnings per share for the current year.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.